Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
140.80
+1.60 (1.15%)
Mar 24, 2026, 10:55 AM AST

TADAWUL:4015 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5011,3181,101916.67735.68
Revenue Growth (YoY)
13.81%19.77%20.09%24.60%-8.65%
Cost of Revenue
565.06500.31399.03325.19260.99
Gross Profit
935.56818.17701.79591.49474.69
Selling, General & Admin
432.55385.36350.42314251.89
Research & Development
38.693433.3932.6837
Other Operating Expenses
-13.22-0.390.08--
Operating Expenses
460.45430.35385.98349.03288.89
Operating Income
475.12387.82315.8242.46185.8
Interest Expense
-0.19-0.1-0.11-0.12-
Interest & Investment Income
4.416.94---
Earnings From Equity Investments
13.8418.574.41-0.32-0.05
Currency Exchange Gain (Loss)
1.19-18.75-1.33-47.952.01
Other Non Operating Income (Expenses)
-1.17-7.3-3.02-6.541.28
EBT Excluding Unusual Items
493.2387.18315.76187.53189.04
Gain (Loss) on Sale of Investments
-0.1-4.520.040.01-1.04
Gain (Loss) on Sale of Assets
---0.030.09
Asset Writedown
----1.25-
Pretax Income
493.1382.65315.8186.31188.09
Income Tax Expense
29.326.1323.41517.39
Earnings From Continuing Operations
463.8356.52292.4171.31170.7
Net Income
463.8356.52292.4171.31170.7
Net Income to Common
463.8356.52292.4171.31170.7
Net Income Growth
30.09%21.93%70.68%0.36%-17.48%
Shares Outstanding (Basic)
7070707010
Shares Outstanding (Diluted)
7070707010
Shares Change (YoY)
---600.00%-
EPS (Basic)
6.635.094.182.4517.07
EPS (Diluted)
6.635.094.182.4517.07
EPS Growth
30.09%21.93%70.68%-85.66%-17.48%
Free Cash Flow
353.25206.47250.74143.2101.9
Free Cash Flow Per Share
5.052.953.582.0510.19
Dividend Per Share
4.0003.0602.500--
Dividend Growth
30.72%22.40%---
Gross Margin
62.34%62.05%63.75%64.53%64.52%
Operating Margin
31.66%29.41%28.69%26.45%25.26%
Profit Margin
30.91%27.04%26.56%18.69%23.20%
Free Cash Flow Margin
23.54%15.66%22.78%15.62%13.85%
EBITDA
517.11424.44341.7266.57209.63
EBITDA Margin
34.46%32.19%31.04%29.08%28.49%
D&A For EBITDA
41.9936.6225.8924.1223.82
EBIT
475.12387.82315.8242.46185.8
EBIT Margin
31.66%29.41%28.69%26.45%25.26%
Effective Tax Rate
5.94%6.83%7.41%8.05%9.25%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.